vorasidenib

INN (International Nonproprietary Name)

🇺🇸 Also approved in the US (FDA)

VORANIGO — SERVIER, approved 2026-06-10 (NDA218784).

Most reported adverse events (US / FAERS)

431 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

alanine aminotransferase increased

63

aspartate aminotransferase increased

51

fatigue

45

malignant neoplasm progression

Medicines containing this active substance

1 medicines

Voranigo

Authorised

🇺🇸 Also approved in the US (FDA)

VORANIGO — SERVIER, approved 2026-06-10 (NDA218784).

Most reported adverse events (US / FAERS)

431 reports across the top reactions. These are spontaneously reported events from the FDA Adverse Event Reporting System — they reflect reporting volume, not incidence or frequency, and a report does not mean the drug caused the event.

alanine aminotransferase increased

63

aspartate aminotransferase increased

51

fatigue

45

malignant neoplasm progression

34

headache

33

hepatic cytolysis

33

seizure

29

nausea

27

hepatic enzyme increased

26

gamma-glutamyltransferase increased

24

hepatotoxicity

15

diarrhoea

14

drug-induced liver injury

14

fall

12

blood bilirubin increased

11